3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 209/04 (2006.01) A61K 31/4045 (2006.01)

Patent

CA 2569238

Compounds of formula I: or pharmaceutically acceptable salts thereof, wherein p, Ar, R1, R2, R3, Ra, Rb, Rc, Rd and Re are defined herein, pharmaceutical compositions containing them and methods of using them for the preparation of medicaments for treating depression or anxiety.

L'invention porte sur des composés de formule (I) ou sur leurs sels acceptables d'un point de vue pharmaceutique, formule dans laquelle p, Ar, R<1>, R<2>, R<3>, R<a>, R<b>, R<c>, R<d> et R<e> sont tels que définis dans le descriptif. L'invention porte également sur des compositions pharmaceutiques contenant ces composés et leurs méthodes d'utilisation dans la préparation de médicaments destinés à traiter la dépression ou l'anxiété.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1510049

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.